Guided Therapeutics (GTHP) Interest Income - Net (2023 - 2025)
Guided Therapeutics' (GTHP) quarterly Interest Income - Net came in at -$157000.0 in Q2 2025, down 109.33% year-on-year from $1.7 million in Q2 2024, and down 6.8% quarter-over-quarter from -$147000.0 in Q1 2025.
Guided Therapeutics (GTHP) Interest Income - Net (2023 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Interest Income - Net across 3 years of filings, most recently posting -$157000.0 for Q2 2025.
- Interest Income - Net for Q2 2025 came in at -$157000.0, down 109.33% year-over-year; the trailing twelve-month figure through Jun 2025 was -$546000.0 (down 100.0% YoY), and the FY2024 annual result was -$378000.0, down 38.97% from the prior year.
- Interest Income - Net came in at -$157000.0 for Q2 2025 at Guided Therapeutics, down from -$147000.0 in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of -$61000.0 in Q1 2024 to a low of -$157000.0 in Q2 2025.
- The 3-year median for Interest Income - Net is -$73000.0 (2023), against an average of -$95400.0.
- Across the five-year window, Interest Income - Net gained 7.58% in 2024 and sank 140.98% in 2025, its largest moves.
- Guided Therapeutics' Interest Income - Net stood at -$66000.0 in 2023, then plunged by 103.03% to -$134000.0 in 2024, then decreased by 17.16% to -$157000.0 in 2025.
- The last three Interest Income - Net figures came in at -$157000.0 (Q2 2025), -$147000.0 (Q1 2025), and -$134000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -157,000.00 |
| Mar 31, 2025 | -147,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Sep 30, 2024 | -108,000.00 |
| Jun 30, 2024 | -75,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2023 | -66,000.00 |
| Sep 30, 2023 | -71,000.00 |
| Jun 30, 2023 | -69,000.00 |
| Mar 31, 2023 | -66,000.00 |